Allergy and Clinical Immunology

1-10 of 10

Turning Cold Tumors Hot with mRNA COVID-19 Vaccines
Turning Cold Tumors Hot with mRNA COVID-19 Vaccines
COVID-19: On The Frontlines
Turning Cold Tumors Hot with mRNA COVID-19 Vaccines
Hallie Blevins, PhD; Marlene Mimi Maeusli, PhD.
- Hallie Blevins, PhD
- Marlene Mimi Maeusli, PhD.
Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
CME/CE
Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
Cem Akin, MD, PhD
0.25 credits
- Cem Akin, MD, PhD
0.25 credits
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
CME/CE
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
Mariana C. Castells, MD, PhD; Tsewang Tashi, MD
0.25 credits
- Mariana C. Castells, MD, PhD
- Tsewang Tashi, MD
0.25 credits
How COVID-19 mRNA Vaccination Restores Sensitivity to Immune Checkpoint Inhibitors
How COVID-19 mRNA Vaccination Restores Sensitivity to Immune Checkpoint Inhibitors
Clinician's Roundtable
How COVID-19 mRNA Vaccination Restores Sensitivity to Immune Checkpoint Inhibitors
Targeting Inflammation to Improve Gene Therapy Outcomes in Sickle Cell Disease
Targeting Inflammation to Improve Gene Therapy Outcomes in Sickle Cell Disease
Clinician's Roundtable
Targeting Inflammation to Improve Gene Therapy Outcomes in Sickle Cell Disease
An Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
An Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
Project Oncology®
An Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
Nanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
Nanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
Project Oncology®
Nanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
Evaluating Alemtuzumab in Adult ALL: Insights from a Phase 1/2 Clinical Trial
Evaluating Alemtuzumab in Adult ALL: Insights from a Phase 1/2 Clinical Trial
Project Oncology®
Evaluating Alemtuzumab in Adult ALL: Insights from a Phase 1/2 Clinical Trial
A Unique Look at the Current and Future Directions of Cancer Vaccines
A Unique Look at the Current and Future Directions of Cancer Vaccines
Project Oncology®
A Unique Look at the Current and Future Directions of Cancer Vaccines
Lillian Siu, MD, FRCPC
- Lillian Siu, MD, FRCPC
A Look at the Horizon of Cancer Vaccines
A Look at the Horizon of Cancer Vaccines
Project Oncology®
A Look at the Horizon of Cancer Vaccines
Lillian Siu, MD, FRCPC
- Lillian Siu, MD, FRCPC

Allergy and Clinical Immunology

1-10 of 10

NEED HELP?

Contact us

NEED HELP?

Contact us

1-10 of 10

Title

Welcome to the newGlobal Oncology Academy website.

Welcome to the new
Global Oncology Academy website.